Peter Olbrich

6PUBLICATIONS
118CO-AUTHORS
AutoimmunityMedical virologyImmunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 21, 2024
A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome.

Raffaele Badolato, Laia Alsina, Antoine Azar

|Jan 12, 2024
Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells.

Julian Staniek, Tomas Kalina, Geoffroy Andrieux

|Feb 25, 2023
Inborn Errors of Immunity Causing Pediatric Susceptibility to Fungal Diseases.

Peter Olbrich, Donald C Vinh

|Jul 21, 2021
Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant.

Pilar Blanco Lobo, Wei-Te Lei, Simon J Pelham

|Jan 15, 2021
Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.

Timothy J Break, Vasileios Oikonomou, Nicolas Dutzan

Pageof 1